No phaseRecruitingAge-related condition
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial of the Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
- Sponsor
- Avisi Technologies Inc. (Industry)
- Enrolment
- 165 planned
- Conditions
- Open Angle Glaucoma (OAG)
- Interventions
- VisiPlate Glaucoma Implant
- Ages
- adults, older adults
- Registry
- NCT07220876
Full record on ClinicalTrials.gov
From the registry
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial
Primary outcomes
- Proportion of subjects (eyes) achieving a ≥ 20% reduction in mean diurnal intraocular pressure
History
Primary completion expected
Last registry update
Started
Registered